JP2003000270A5 - - Google Patents

Download PDF

Info

Publication number
JP2003000270A5
JP2003000270A5 JP2001306811A JP2001306811A JP2003000270A5 JP 2003000270 A5 JP2003000270 A5 JP 2003000270A5 JP 2001306811 A JP2001306811 A JP 2001306811A JP 2001306811 A JP2001306811 A JP 2001306811A JP 2003000270 A5 JP2003000270 A5 JP 2003000270A5
Authority
JP
Japan
Prior art keywords
peptide
polynucleotide
recombinant vector
complementary strand
transformant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001306811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003000270A (ja
JP4097178B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001306811A priority Critical patent/JP4097178B2/ja
Priority claimed from JP2001306811A external-priority patent/JP4097178B2/ja
Publication of JP2003000270A publication Critical patent/JP2003000270A/ja
Publication of JP2003000270A5 publication Critical patent/JP2003000270A5/ja
Application granted granted Critical
Publication of JP4097178B2 publication Critical patent/JP4097178B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001306811A 2000-10-03 2001-10-02 腫瘍抗原 Expired - Lifetime JP4097178B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001306811A JP4097178B2 (ja) 2000-10-03 2001-10-02 腫瘍抗原

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-304155 2000-10-03
JP2000304155 2000-10-03
JP2001121452 2001-04-19
JP2001-121452 2001-04-19
JP2001306811A JP4097178B2 (ja) 2000-10-03 2001-10-02 腫瘍抗原

Publications (3)

Publication Number Publication Date
JP2003000270A JP2003000270A (ja) 2003-01-07
JP2003000270A5 true JP2003000270A5 (enExample) 2005-06-23
JP4097178B2 JP4097178B2 (ja) 2008-06-11

Family

ID=27344853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001306811A Expired - Lifetime JP4097178B2 (ja) 2000-10-03 2001-10-02 腫瘍抗原

Country Status (1)

Country Link
JP (1) JP4097178B2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2520868A1 (en) * 2003-03-31 2004-10-14 Intercell Ag Staphylococcus epidermidis antigens
JP4579581B2 (ja) * 2003-12-08 2010-11-10 株式会社グリーンペプタイド 副甲状腺ホルモン関連タンパク質のｈｌａ−ａ２４またはｈｌａ−ａ２結合ペプチド
ES2390967T3 (es) 2004-01-20 2012-11-20 Aichi Prefecture Epítopo/péptido reconocido por LTC específico para Ep-CAM con restricción por ALH-A2402 y su utilización
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
EP2038301A4 (en) 2006-07-12 2010-01-20 Oncotx Inc COMPOSITIONS AND METHODS OF TARGETING CANCER-SPECIFIC TRANSCRIPTION COMPLEXES
WO2009038026A1 (ja) 2007-09-18 2009-03-26 Kurume University Ｃｔｌ誘導剤組成物
JP5706895B2 (ja) 2010-07-07 2015-04-22 株式会社グリーンペプタイド がんペプチドワクチン
US9522943B2 (en) 2012-03-02 2016-12-20 Rhode Island Hospital, A Lifespan-Partner Treating human immunodeficiency virus infections
CA2901984A1 (en) 2013-03-08 2014-09-12 Taiho Pharmaceutical Co., Ltd. Novel peptide having 5 linked ctl epitopes
ES2796301T3 (es) * 2013-10-21 2020-11-26 Taiho Pharmaceutical Co Ltd Nuevo péptido con cuatro epítopos CTL unidos
TWI805792B (zh) 2018-06-29 2023-06-21 日商大鵬藥品工業股份有限公司 抗腫瘤劑及其評估方法
EP4082563A4 (en) 2019-12-26 2024-02-28 Taiho Pharmaceutical Co., Ltd. POST-OPERATIVE ADJUVANT THERAPY AGENT

Similar Documents

Publication Publication Date Title
ES2582459T3 (es) Composiciones de variantes de fenilalanina amoníaco-liasa de procariotas y métodos de uso de sus composiciones
MXPA04008077A (es) Anticuerpos ant-a° y su uso.
JP2006525330A5 (enExample)
RU2001134170A (ru) Антигенные пептиды NEISSERIA
JP2003000270A5 (enExample)
DE2967652D1 (en) Recombinant dna, hosts transformed with it and polypeptides produced by the hosts; processes for their preparation; detection processes using the polypeptides; compositions and means containing the polypeptides; dna sequences
RU2002113920A (ru) Антигенные пептиды neisseria
DE60041265D1 (de) Verwendung eines polypeptids zur auffindung von multipler sklerose
CA2417570A1 (en) Tumor-specific t cell activation by peptide antigens
EP2292644A3 (en) Small Streptococcus pyogenes antigens and their use
RU2007139915A (ru) Haemophilus influenzae типа в
IL93397A (en) Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens
JP2002517193A5 (enExample)
WO2001096527A3 (en) Peptides with physiological activity
WO2007064844A3 (en) Anti-viral griffithsin compounds, compositions, and methods of use
RU2011116286A (ru) Многокомпонентная иммуногенная композиция для предупреждения заболевания, вызванного бета-гемолитическими стрептококками(бгс)
CA2338886A1 (en) Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
JP2005510211A5 (enExample)
SE9901601D0 (sv) Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus
RU2007106900A (ru) Иммуногенные комплексы, способ их приготовления и их применение в фармацевтических композициях
JP2005524387A5 (enExample)
EP1439229A3 (en) Oncogene, recombinant protein derived therefrom, and uses thereof
WO2008029138A3 (en) Peptides and methods
ATE458037T1 (de) Grosstechnisch geeigneter mikroorganismus
JP2002335976A5 (enExample)